Shares of Oscar Health, Inc. (NYSE:OSCR – Get Free Report) have earned a consensus recommendation of “Hold” from the thirteen analysts that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation, four have issued a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $34.90.
OSCR has been the topic of several recent analyst reports. UBS Group increased their price objective on shares of Oscar Health from $26.00 to $36.00 and gave the company a “neutral” rating in a research report on Monday, October 12th. Wells Fargo & Company boosted their price objective on Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a research note on Thursday, August 13th. Weiss Ratings upgraded Oscar Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. The Goldman Sachs Group reissued a “neutral” rating and issued a $34.00 price objective on shares of Oscar Health in a research note on Thursday, September 17th. Finally, Raymond James Financial boosted their price objective on Oscar Health from $34.00 to $42.00 and gave the stock an “outperform” rating in a research note on Friday, September 18th.
View Our Latest Research Report on Oscar Health
Insider Activity at Oscar Health
In related news, CAO Victoria Baltrus sold 958 shares of the company’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $30,129.10. Following the transaction, the chief accounting officer directly owned 213,631 shares in the company, valued at approximately $6,718,694.95. This represents a 0.45% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Adam Mcananey sold 9,092 shares of the firm’s stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $285,943.40. Following the completion of the sale, the insider directly owned 209,004 shares of the company’s stock, valued at approximately $6,573,175.80. The trade was a 4.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 874,451 shares of company stock worth $26,761,671 in the last ninety days. Corporate insiders own 22.64% of the company’s stock.
Hedge Funds Weigh In On Oscar Health
Institutional investors have recently modified their holdings of the stock. XML Financial LLC purchased a new position in Oscar Health during the 3rd quarter worth $303,000. Vise Technologies Inc. increased its position in Oscar Health by 25.4% during the 3rd quarter. Vise Technologies Inc. now owns 17,067 shares of the company’s stock valued at $526,000 after buying an additional 3,461 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in Oscar Health in the third quarter valued at about $632,000. Hanseatic Management Services Inc. raised its stake in Oscar Health by 2.1% in the third quarter. Hanseatic Management Services Inc. now owns 53,718 shares of the company’s stock valued at $1,657,000 after buying an additional 1,114 shares during the last quarter. Finally, Oppenheimer & Co. Inc. boosted its holdings in Oscar Health by 0.8% in the third quarter. Oppenheimer & Co. Inc. now owns 68,428 shares of the company’s stock worth $2,110,000 after acquiring an additional 574 shares in the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.
Oscar Health Stock Performance
Shares of OSCR opened at $30.23 on Friday. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. The business’s 50 day moving average price is $31.68 and its 200-day moving average price is $23.58. Oscar Health has a 52 week low of $10.69 and a 52 week high of $35.01. The stock has a market cap of $9.33 billion, a P/E ratio of 21.59, a P/E/G ratio of 0.34 and a beta of 2.47.
Oscar Health (NYSE:OSCR – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%. The business had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.73 billion. During the same period in the previous year, the company posted ($0.89) earnings per share. The company’s revenue for the quarter was up 70.4% compared to the same quarter last year. Equities research analysts anticipate that Oscar Health will post 1.83 earnings per share for the current fiscal year.
Oscar Health Company Profile
Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.
Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.
Read More
- Five stocks we like better than Oscar Health
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.
